Urolithin A: Mitophagy Flux and B2B Grade Specifications
Apr 05, 2026
Leave a message
Does Urolithin A solve the "Non-Producer" microbiome bottleneck?
The biological reality of pomegranate consumption is frustrating: roughly 60% of humans lack the specific gut flora (Gordonibacter) required to synthesize Urolithin A from ellagitannins. For a B2B brand, this is the "Non-Producer" gap. We aren't just pitching another antioxidant; we're supplying a metabolic bypass.
By providing a 98% HPLC-pure direct metabolite, we eliminate the variable of gut microbiome diversity. Formulators can now guarantee a precise, bioavailable mitophagy trigger-selective clearing of dysfunctional mitochondria-regardless of the end-user's internal microbial landscape. It's molecular precision, not dietary hope.
Why do residual catalysts jeopardize Urolithin A shelf-life?
A 98.0% CoA (Certificate of Analysis) is often a mask. In the synthesis of Urolithin A, the real concern isn't the 98% purity, but the toxicological profile of the remaining 2%. At Xi'an Tihealth, we focus on "Invisible Impurities"-specifically residual Palladium (Pd) and Copper (Cu) from the coupling phase. These metal traces, if left above 10ppm, act as pro-oxidants in the final formulation, degrading other actives in the blend.
Furthermore, we monitor the "Polymorphic Crystalline Phase." If the crystal lattice isn't stabilized during the drying process, the powder will clump and lose flowability in high-speed encapsulation lines. If your supplier doesn't discuss polymorphic stability, they aren't providing API-grade material.
Is D90 micronization a luxury or a formulation necessity?
Urolithin A is effectively "brick dust" in its raw state-highly lipophilic and stubbornly insoluble. High purity is irrelevant if the material passes through the GI tract unabsorbed. This is where particle engineering dictates efficacy.
We've moved beyond standard milling to Supercritical Jet Micronization, targeting a D90 < 10 μm distribution. This isn't a marketing gimmick; it increases the effective surface area by nearly 400%, forcing the dissolution rate to spike in the small intestine. For premium longevity supplements, this micronization is the only way to ensure the active survives the first-pass metabolism and reaches the systemic circulation.
Urolithin A Technical Data Sheet (TDS)
|
Technical Parameters |
Specification (Pharma/Research Grade) |
Test Method |
|
IUPAC Name |
3,8-Dihydroxy-6H-dibenzo[b,d]pyran-6-one |
-- |
|
Appearance |
Fine Off-white Crystalline Powder |
Visual |
|
Assay (Purity) |
≥ 98.0% |
HPLC (Internal Method SOP-UA-05) |
|
Identification |
Corresponds to Reference Standard |
1H-NMR / LC-MS |
|
Particle Size (D90) |
≤ 10 μm |
Laser Diffraction (Malvern 3000) |
|
Heavy Metals (Pb) |
≤ 10 ppm |
ICP-MS |
|
Residual Solvents |
Ethanol ≤ 5000ppm; Methanol ≤ 3000ppm |
GC-Headspace |
|
Loss on Drying |
≤ 1.0% |
Vacuum Oven (105°C, 3h) |
References
-
Cell Metabolism: Urolithin A induces mitophagy and prolongs lifespan. https://www.cell.com/cell-metabolism/fulltext/S1550-4131(16)30251-2
-
Nature Medicine: The mitophagy activator urolithin A is safe in humans. https://www.nature.com/articles/s41591-019-0473-2
-
JAMA Network Open: Urolithin A Supplementation on Muscle Endurance. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2788244
FAQ Section
Q: Why does the batch color vary from off-white to pale yellow?
A: Minor chromatic shifts are inherent to high-purity polyphenolic metabolites. This is typically tied to the drying kinetics and the resulting crystalline polymorph. As long as the HPLC assay confirms ≥ 98.0%, these aesthetic variations have zero impact on the mitophagy-inducing potency.
Q: Is Xi'an Tihealth's Urolithin A suitable for lipid-based softgels?
A: Absolutely. Given its lipophilic profile, Urolithin A is ideally formulated with MCT oil or lecithin. Our micronized D10/D50/D90 control ensures the material stays in suspension, preventing "slugging" or sedimentation during the softgel filling process.
Q: How do you control for residual synthesis intermediates?
A: We perform full-spectrum LC-MS on every batch. We specifically track "marker impurities" like resorcinol and 2-bromo-5-hydroxybenzoic acid. We adhere to ICH Q3A guidelines to ensure these intermediates are well below the thresholds required for pharmaceutical intermediates.
Send Inquiry





